Brassicasterol - CAS 474-67-9

Brassicasterol, as a metabolite of ergosterol, exhibits cardiovascular protective properties. This compound demonstrates antitumor effects in prostate cancer through dual targeting of AKT and androgen receptor signaling pathways. Brassicasterol shows inhibitory activity against HSV-1 (IC50=1.2 μM) and Mycobacterium tuberculosis. By inhibiting sterol δ24-reductase, it delays atherosclerosis progression and has been identified as a cerebrospinal fluid biomarker for Alzheimer's disease.

Androgen Receptor, Akt, HSV, Drug Metabolite, Antibacterial

PI3K/Akt/mTOR signaling, Cytoskeletal Signaling, Metabolism, Microbiology/Virology, Endocrinology/Hormones

398

0.9858

C28H46O

398.66

C[C@@]12[C@]([C@]3([C@@]([C@]4(C)C(=CC3)C[C@@H](O)CC4)(CC1)[H])[H])(CC[C@@]2([C@@H](/C=C/[C@@H](C(C)C)C)C)[H])[H]

-20°C

Ice Packs

Natural Product